Iscador.
After careful study of the literature and other information available to it, the American Cancer Society does not have evidence that treatment with Iscador, an extract of mistletoe, results in objective benefit in the treatment of cancer in human beings. Lacking such evidence, the American Cancer Society would strongly urge individuals afflicted with cancer not to participate in treatment with Iscador.
D000570:American Cancer Society; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D005060:Europe; D006801:Humans; D010936:Plant Extracts / Q000627:therapeutic use*; D010940:Plant Proteins; D014481:United States; D014486:United States Food and Drug Administration
D000972:Antineoplastic Agents, Phytogenic; D010936:Plant Extracts; D010940:Plant Proteins; C077177:viscum album peptide